• Bookmark and Share

News about Magnesium Sulfate

Last Updated on Tuesday, June 04, 2013

 Magnesium sulfate is approved to prevent seizures in preeclampsia, a condition in which the pregnant woman develops high blood pressure and protein in the urine, and for control of seizures in eclampsia. Both preeclampsia and eclampsia are life-threatening complications that can occur during pregnancy. Preeclampsia can lead to eclampsia, seizures, stroke, multiple organ failure, and death of the woman and/or baby.

Editor’s Note: Even though this does not impact the use of magnesium sulfate for preeclampsia, we thought it important to share news about one of the only drug interventions known for clinical management of preeclampsia.

The FDA is now advising health care professionals against using magnesium sulfate injection for more than 5-7 days to stop pre-term labor in pregnant women. Administration of magnesium sulfate injection to pregnant women longer than 5-7 days may lead to low calcium levels and bone problems in the developing baby or fetus, including thin bones (osteopenia), and fractures. The shortest duration of treatment that can result in harm to the baby is not known.

The FDA’s full article provides more information that will be added to the drug label for Magnesium Sulfate Injection, USP 50%. Pregnant women should discuss with their health care professional the possibility of going into labor before term and the risks and benefits of any treatments that may be used.

UPCOMING EVENTS

We’ll be Speaking Here

 

 

Grand Rounds, University of Miami
December 15, 2016
Miami, Florida

Invite Us to Speak at Your Event

 

Preeclampsia in the News

Featured Video

What’s Happening on Twitter

Preeclampsia RT @Eleni_Z_Tsigas: Honored to address why we need to do more for maternal mortality and morbidity @IHIForum in memory of #christie #joan #…
17hreplyretweetfavorite
Preeclampsia RT @Pfccpartners: We will be live tweeting from the PFASummit @TheIHI #ihiforum #PFANetwork starting tomorrow morning @ 8a est! Join us!
19hreplyretweetfavorite

Press Releases by Year

Other Resources

JOIN OUR MAILING LIST. We respect your privacy.